29 related articles for article (PubMed ID: 3314264)
1. Letter: Susceptibility to group B meningococcal vs. Escherichia coli K1 disease.
Ericsson CD
N Engl J Med; 1975 Apr; 292(14):755. PubMed ID: 803639
[No Abstract] [Full Text] [Related]
2. An "omics" approach to uropathogenic Escherichia coli vaccinology.
Sivick KE; Mobley HL
Trends Microbiol; 2009 Oct; 17(10):431-2. PubMed ID: 19758805
[No Abstract] [Full Text] [Related]
3. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
Straube E; Nimmich W; Broschewitz U; Naumann G
Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
[TBL] [Abstract][Full Text] [Related]
4. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
Straube E; Naumann G; Broschewitz U
Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
[TBL] [Abstract][Full Text] [Related]
5. [Local autovaccine treatment of experimental urinary tract infections in the rat].
Straube E; Broschewitz U
Z Urol Nephrol; 1988 Jan; 81(1):1-12. PubMed ID: 3284238
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary results of the vaccine treatment of chronic pyelonephritis in animal experiments].
Straube E; Broschewitz U; Schill H; Naumann G
Z Urol Nephrol; 1984 Jul; 77(7):401-5. PubMed ID: 6385543
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunization with Escherichia coli K1 antigen on the course of experimental infection of the urinary tract of the rat.
Straube E; Nimmich W; Broschewitz U; Naumann G; Hacker K
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):408-19. PubMed ID: 3314264
[TBL] [Abstract][Full Text] [Related]
8. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
[TBL] [Abstract][Full Text] [Related]
9. Neonatal meningitis due of Escherichia coli K1.
Glode MP; Sutton A; Robbins JB; McCracken GH; Gotschlich EC; Kaijser B; Hanson LA
J Infect Dis; 1977 Aug; 136 Suppl():S93-7. PubMed ID: 330780
[TBL] [Abstract][Full Text] [Related]
10. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
[TBL] [Abstract][Full Text] [Related]
11. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
